Cambridge, UK, 23 July 2024: Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.
News
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Appointment of experienced pre-clinical CRO specialist to support accelerated expansion into key global markets
Genetically engineered iPSCs offer improved efficiency and cost savings.
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.
Astex Pharmaceuticals is pleased to share the below news which was today Issued by its collaborator The Institute of Cancer Research, London,
MHRA approves first-in-class breast cancer drug
• MHRA approves first-in-class drug Truqap (capivasertib) in combination with fulvestrant for treating HR-positive, HER-2 negative locally advanced breast cancer with specific biomarker alterations (PIK3CA, AKT1 or PTEN) alterations following recurrence or progression on or after an endocrine based regimen
Protagene has added cell based bioassay driven structure-function correlation to its extensive portfolio of MS and biophysical methods. Non GMP assays are available immediately, with GMP level assays becoming available in August.
To discuss this or any other analytical requirements, please contact colin.crowley@protagene.com
Cambridge, UK – July 17th 2024 - The Cambridge Crystallographic Data Centre (CCDC) is excited to highlight that its CSD-Particle suite of advanced informatics tools is now being actively used to revolutionize the understanding of particle behaviour and surface properties in pharmaceutical and fine chemical manufacturing. The suite provides easy to use digital methods to enhance the efficiency of product formulation and reduce manufacturing costs.
Pharmaron's DMPK Insights Podcast Episode #8: “It’s ‘All-go’ with Oligos: Challenges and Opportunities in LC-MS of Therapeutics.”
Menopause care provider Minter Hormone Health wins Femtech and Women’s Health competition
The Femtech & Women’s Health edition of ‘Discovery Spark’ supports early stage businesses working to close the gender health gap